Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $3.34 million. The enterprise value is $6.01 million.

Market Cap	3.34M
Enterprise Value	6.01M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

APVO has 676,804 shares outstanding.

Current Share Class	676,804
Shares Outstanding	676,804
Shares Change (YoY)	n/a
Shares Change (QoQ)	+78.66%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	243.85%
Float	6.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,023.93% and return on invested capital (ROIC) is -201.28%.

Return on Equity (ROE)	-1,023.93%
Return on Assets (ROA)	-115.99%
Return on Invested Capital (ROIC)	-201.28%
Return on Capital Employed (ROCE)	-817.19%
Revenue Per Employee	n/a
Profits Per Employee	-$640,649
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.06% in the last 52 weeks. The beta is 6.06, so APVO's price volatility has been higher than the market average.

Beta (5Y)	6.06
52-Week Price Change	-99.06%
50-Day Moving Average	19.48
200-Day Moving Average	118.79
Relative Strength Index (RSI)	25.66
Average Volume (20 Days)	360,910

Short Selling Information

The latest short interest is 452,279, so 66.83% of the outstanding shares have been sold short.

Short Interest	452,279
Short Previous Month	703,573
Short % of Shares Out	66.83%
Short % of Float	7.22%
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	171,000
Operating Income	-24.10M
Pretax Income	-24.95M
Net Income	-23.70M
EBITDA	-23.79M
EBIT	-24.10M
Earnings Per Share (EPS)	-$745.27

Full Income Statement

Balance Sheet

The company has $2.14 million in cash and $4.42 million in debt, giving a net cash position of -$2.28 million or -$3.37 per share.

Cash & Cash Equivalents	2.14M
Total Debt	4.42M
Net Cash	-2.28M
Net Cash Per Share	-$3.37
Equity (Book Value)	-1.47M
Book Value Per Share	-20.20
Working Capital	-1.79M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.71M
Capital Expenditures	n/a
Free Cash Flow	-23.71M
FCF Per Share	-$35.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-635.86%
FCF Yield	-636.00%

Analyst Forecast

The average price target for APVO is $296.00, which is 5,896.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$296.00
Price Target Difference	5,896.27%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.027027:1.

Last Split Date	Dec 4, 2024
Split Type	Reverse
Split Ratio	0.027027:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a